CPC

18 Jun 2016

KD Modifier


KD modifier was created by Medicare.

 

Any “Drug or biological substance infused through a DME (Durable Medical Equipment's),” Since the infusion of medications take place through an implantable pump (External Pump), then we should append modifier KD to the HCPCS code for that drug/biological substance. 

 

Medicare Part B covers a small number of home infusion drugs through the DME benefit. To be covered under the Part B DME drug benefit, the drug must require administration through an implanted DME infusion pump and the administration of the drug in the home must be medically necessary - as per CMS

 

The infusion drugs must be billed with the appropriate CPT code 62367, 62368, 95990, 95991 or 96522 on the same claim.

 

CPT 62367 - Electronic analysis of programmable, implanted pump for intrathecal or epidural drug infusion (includes evaluation of reservoir status, alarm status, drug prescription status); without reprogramming or refill

 

CPT 62368 – Electronic analysis of programmable, implanted pump for intrathecal or epidural drug infusion (includes evaluation of reservoir status, alarm status, drug prescription status); with reprogramming

 

CPT 95990 - Refilling and maintenance of implantable pump or reservoir for drug delivery, spinal (intrathecal, epidural) or brain (intraventricular), includes electronic analysis of pump, when performed

 

CPT 95991 – Refilling and maintenance of implantable pump or reservoir for drug delivery, spinal (intrathecal, epidural) or brain (intraventricular), includes electronic analysis of pump, when performed; requiring the skill of a physician or other qualified health care professional

 

CPT 96522 - Refilling and maintenance of implantable pump or reservoir for drug delivery, systemic (e.g.: intravenous, intra-arterial)

 

Reimbursement:

 

Medicare pay - The payment limit for these drugs shall be 95 percent of October 1, 2003 AWP (Average Wholesale Price)

 

(Medicare Part B Coverage of Infusion Pumps In infusion therapy, drugs are typically administered intravenously using a needle, catheter, or device such as an infusion pump to control the rate of drug flow.

 

Physicians often prescribe infusion therapy when oral medications may not effectively treat the patient’s condition.

 

Infusion therapy is commonly used to treat acute conditions, such as pain and infections, and chronic conditions, such as cancer, multiple sclerosis, and rheumatoid arthritis.

 

Infusion therapy is often provided in the home rather than in inpatient settings to reduce costs associated with inpatient care and maintain patient convenience and comfort.

 

In general, external and implantable pumps used in infusion therapy are covered by Medicare under the DME benefit when they are used as specified by the Medicare National Coverage Determinations Manual. 

 

For example, Medicare covers external infusion pumps when used to treat iron poisoning, thromboembolic disease, and diabetes, among other conditions. Implantable infusion pumps are covered when they are used to treat certain conditions, including chronic intractable pain, chronic intractable spasticity, and liver cancer. - CMS)

 

Some payers may allow us to bill KD modifier but it doesn’t change the reimbursement, few payers may not accept the KD modifier they may deny the claim, Hence check with your payers.

 

Note: KD modifier must be placed in the first modifier position when multiple pricing or payment modifiers are submitted.